Bioprocessing Market Size and Forecast (2021-2031)
Bioprocessing Market Size and Forecast (2021 – 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
$4,152 – $7,352
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Bioprocessing increases the number of living cells or other biological systems/components (such as bacteria, enzymes, proteins, viruses, or nucleic acids) in a commercial bioreactor for biopharmaceutical manufacturing. Products produced in the bioprocessing sector typically contain high-quality therapeutics and vaccines critical to modern healthcare advancement. The current bioprocessing industry landscape is characterized by dynamic developments driven by advances in biotechnology and increasing demand for biopharmaceuticals. The increase in demand is attributed to the prevalence of chronic diseases, the growing adoption of personalized medicine, and increasing bioprocessing applications in various sectors. As bioprocessing becomes significantly important in producing therapeutic proteins, vaccines, and other bio-based products, it turns out to be a key enabler of the biotechnological revolution. The market is progressing toward meeting the demands of a changing healthcare landscape, and the need for efficient and scalable bioproduction processes is expected to bring new bioprocessing market trends in the coming years.
Growing Biopharmaceutical Industry Drives the Bioprocessing Market
In the biopharmaceutical industry, improved bioprocesses are always in demand to address new regulatory requirements, quality control requirements, and production issues in biological products, cell culture titration, and biosimilar production. In recent years, the biopharmaceutical industry has been growing at an unprecedented pace. Biopharmaceutical companies are spending huge sums in R&D to introduce new molecules with enhanced medical and commercial potency for various therapeutic applications. The acceptance of bioprocessing is gradually increasing due to its wide application in research, development, and manufacturing of biologics and biosimilars. Big pharmaceutical companies and contract research organizations are coming up with new medicines and therapy forms to treat a wide range of indications. Further, a strong demand for biologics and biosimilars to treat chronic diseases is, in turn, driving the growth of the biopharmaceutical industry. The biopharmaceutical industry is one of the most significant contributors to the economy. The US is the largest market for biopharmaceuticals and the leader in biopharmaceutical R&D. As per the Pharmaceutical Research and Manufacturers Association, the US firms conduct over half the world’s R&D in pharmaceuticals (US$ 75 billion) and hold the highest number of patents in new medicines. Besides growing economies, rapid growth is witnessed in the research environment in emerging economies such as Brazil, China, and India. Factors such as increasing biologics approval, growing biosimilar pipeline, rising investment in research activities, and increasing focus on developing affordable biologics are facilitating the growth of the biopharmaceutical industry.
Apart from these, increasing approvals in gene and cell therapies are favoring the bioprocessing market growth. The approved gene therapies are Glybera (to treat lipoprotein lipase deficiency) and Strimvelis (to treat ADA-severe combined immunodeficiency). Thus, the factors mentioned above are increasing the demand for the large-scale production of various therapeutics, thereby facilitating the growth of the bioprocessing market globally.
Market Trend
Shift Toward Automated Cell Therapy Manufacturing
A rising number of cell therapies have shifted the production of cell therapy products from a small volume to a large volume worldwide. Increasing research activities in cell therapies have led to a rise in the demand for advanced manufacturing solutions. In view of this, many players are offering products to meet the needs of academic researchers and large biotechnology companies. For instance, the Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are designed to enable the automation of most sequential unit operations for a CAR-T process within a single system. In addition, the evolution of cell therapy—from an academic and clinical setting to mass production and commercialization—is increasing the demand for automation in manufacturing. In May 2019, GE Healthcare launched the Chronicle web application to support the complete cell therapy workflow. Chronicle automation software is a good manufacturing practice-compliant digital solution designed to optimize complex cell therapy process development and manufacturing. Companies are also entering into strategic and technological developments for automation in cell therapy. For instance, in July 2020, Thermo Fisher Scientific Inc. and Lyell Immunopharma partnered to develop and manufacture processes to design effective cell therapies for cancer patients. Under this partnership, the companies aim to improve the fitness of T-cells and support the development of an integrated cGMP-compliant platform (system and software) along with reagents, consumables, and instruments. In March 2019, Lonza partnered with Israel’s Sheba Medical Center to provide automated and closed CAR-T manufacturing using its point-of-care Cocoon cell therapy manufacturing platform.
Automated procedures can drastically reduce the production cost and enhance staff productivity and retention rates. Other than these factors, automated processes restrict various possible sources of contamination in the manufacturing unit and eventually enhance process consistency, which results in overall good quality products by reducing manual errors. Thus, the increasing adoption of automation among cell therapy manufacturers and the growing product innovations in the field of cell therapy are likely to boost cell therapy bioprocessing or manufacturing.
The “Global Bioprocessing Market” is segmented on the basis of product, scale of operation, process, application, end user, and geography.
Product-Based Insights
Based on product type, the bioprocessing market is segmented into instruments, and consumables and accessories. The instruments segment held a larger market share in 2023 and is anticipated to register a higher CAGR of 14.5% during the forecast period. The instruments segment includes chromatography systems, filtration devices, osmometers, incubators, centrifuges, drying devices, and bioreactors. From pilot to process scale, chromatography systems are intended to provide persistent performance with processing flexibility as per the client’s requirement. Sartorius AG offers Resolute BioSC Pilot Multi-Column Chromatography Systems—configurable automated systems with scalability that boost comprehensive support in pre- and post-sales. Ongoing advancements in bioreactor designs have led to the development of sophisticated systems capable of accommodating a range of cell types, from mammalian and microbial cells to plant and insect cells. Moreover, the use of single-use and flexible bioreactor technologies has gained prominence, offering scalability, flexibility, and reduced contamination risks. Advances in filtration technologies have led to the development of advanced filter media, such as depth filters, membrane filters, and chromatographic resins, offering enhanced capture efficiency, scalability, and purity for bioprocessing applications.
Process-Based Insights
Based on process, the bioprocessing market is segmented into downstream bioprocess and upstream bioprocess. The downstream bioprocess segment dominated the bioprocessing market share in 2023 and is anticipated to register a higher CAGR of 14.4% during the forecast period. The upstream bioprocess accounted for 31.2% of the market share. Upstream bioprocessing is critical for the product’s success, as it sets the foundation for the quality and quantity of the resultant product. Upstream bioprocessing points toward the initial stages of the production process in which microbes, cells, and bacteria are grown, nurtured, and developed through various technologies and media. These steps are complex and challenging, as high control is required over cell cultures and the environment in which cells are grown. The stages of upstream bioprocessing are cell isolation, cultivation, cell banking, and culture expansion. Furthermore, it is anticipated that technologies such as artificial intelligence and machine learning will be essential in upstream bioprocessing.
US Food and Drug Administration, Global Cancer Observatory, World Health Organization, Organization for Economic Co-operation and Development, National Human Genome Research Institute, International Trade Administration, and Pharmaceutical Research and Manufacturers Association are some of the relevant sources referred while preparing the bioprocessing market research report.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
Factors such as the increasing prevalence of chronic diseases and the growing biopharmaceutical industry propel the bioprocessing market growth. However, stringent regulatory policies and limitations associated with bioprocessing impede the market’s growth.
Proliferating Demand for Personalized Medicine Creates Opportunities for the Bioprocessing Market
The healthcare industry’s transformation from one-size-fits-all to a targeted approach is expanding the demand for personalized medicine. Precision medicine is being considered as one of the most promising approaches to tackle health concerns such as cancer, neurodegenerative diseases, and rare genetic conditions. Innovations in the production of personalized medicines are likely to impact the entire sector, and single-use technologies aimed at smaller-volume production have potential applications in protein bioproduction, particularly in downstream processes. Personalized and differentiated approaches to medicine are leading to a need for a wider range of products—many of them for a relatively small group of patients. Therefore, a fundamentally different approach to producing and delivering biological products may be required.
Precision medicine utilizes an individual’s genomic information to offer targeted treatment for a particular indication. The growing number of orphan diseases has increased the demand for biologics and drugs, subsequently boosting personalized medicines’ growth. In 2019, the FDA approved ~12 personalized medications for addressing the root causes of disease and further integrated precision medicine with clinical care. Also, increasing government efforts are strengthening personalized medicine research activities. For instance, in February 2020, the National Human Genome Research Institute (NHGRI) announced to establish a new precision medicine and genomics program. This program focuses on the innovation of genomics and informatics tools for better diagnosis and treatment of disease.
Personalized medicines leverage advances in genetics and bioinformatics to target specific patient populations and treat previously untreatable diseases. Personalized medicine uses bioprocessing techniques to develop tailored therapies. From isolating specific cells to developing patient-specific treatments, bioprocessing steps are essential for producing treatments tailored to each patient. Therefore, the rising demand for personalized medicine is predicted to offer significant growth opportunities to the players operating in the bioprocessing market during the forecast period.
The “Global Bioprocessing Market” is segmented on the basis of Product, Scale Of Operation, Process, Application, End User, and Geography.
Product Overview
Based on product, the bioprocessing market is segmented into instruments, consumables, and accessories. The instruments segment held a larger market share in 2023 and is anticipated to register a higher CAGR of 14.5% during the forecast period.
Scale of Operation Overview
Based on scale of operation, the bioprocessing market is segmented into commercial operations and clinical operations. The commercial operations segment held a larger bioprocessing market share in 2023 and is anticipated to register a higher CAGR during the forecast period.
Process Overview
The bioprocessing market, based on process, is divided into downstream bioprocess and upstream bioprocess. The downstream bioprocess segment held a larger market share in 2023 and is anticipated to register a higher CAGR of 14.4% during 2023–2031. Downstream bioprocessing is the stage where the upstream bioproduct is recovered, concentrated, and purified to meet quality requirements. Downstream bioprocessing is applicable in the purification of monoclonal antibodies or proteins and manufacturing of oligonucleotides, polysaccharides, and various vaccines. The steps associated with downward bioprocessing are harvest and filtration, capture, ultrafiltration, purification, bioconjugation, and formulation.
End User Overview
Based on end user, the bioprocessing market is divided into biopharmaceutical companies, contract manufacturing organization, and others. The biopharmaceutical companies segment held the largest bioprocessing market share in 2023; the contract manufacturing organization segment is anticipated to register the highest CAGR of 14.7% during 2023–2031. The number of biopharmaceutical companies is increasing worldwide, leading to a high number of collaborations and agreements between the companies. Investments by companies in the research and development of drugs and other biosimilars have been increased. The advancement in biotechnology has improved the identification of possible targets for a drug. The rising application of bioprocessing in cancer therapeutics and the ability of biopharmaceuticals to address untreatable conditions are expected to accelerate the market growth
The global bioprocessing market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The North America regional market is expected to grow with a CAGR of 14.2% during 2023–2031. The North America bioprocessing market is segmented into the US, Canada, and Mexico. Market growth in the region is due to the increasing incidence of rare diseases and the rising trend of cell and gene therapy (CGT). Growing incidences of genetic and cellular disorders are leading to increasing demand for cell therapies. In April 2023, Cytiva launched X-platform bioreactors to simplify upstream bioprocessing operations with single-use products. The increasing R&D investments by US-based biopharmaceutical and biotechnology companies to improve outcomes of clinical trials and ensure patient safety, and the growing traction toward precision medicine with rising investments by the US government contribute to the growth of the bioprocessing market in the US. Asia Pacific is expected to register the highest CAGR of 15.1% during 2023–2031. The Asia Pacific bioprocessing market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest market share in 2023, and India is expected to show a significant growth rate in the market. The biopharmaceutical industry in China is undergoing a tremendous shift, evolving from a generics-focused landscape to a thriving innovation hub. India’s bioprocessing capability is highly dependent on its qualified workforce and cost efficiencies, which creates growth opportunities for the market.
Bioprocessing Market, by Region, 2023 (%)
Source: the Research Team Analysis
Cytiva (Danaher Corporation), Sartorius AG, Thermo Fisher Scientific Inc., Repligen Corporation, Merck KgaA, 3M Company, Getinge AB, Eppendorf SE, Corning Incorporated, Entegris, Agilent Technologies, and Bio-Rad Laboratories are among the leading market players of bioprocessing market. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which allows them to serve a large set of customers and subsequently increase their market share.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the global bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth global bioprocessing market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Bioprocessing Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. Bioprocessing Market – Key Market Dynamics
5.1 Bioprocessing Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Chronic Diseases
5.2.2 Growing Biopharmaceutical Industry
5.3 Market Restraints
5.3.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.4 Market Opportunities
5.4.1 Proliferating Demand for Personalized Medicine
5.5 Future Trends
5.5.1 Shift Toward Automated Cell Therapy Manufacturing
5.6 Impact of Drivers and Restraints:
6. Bioprocessing Market – Global Market Analysis
6.1 Bioprocessing Market Revenue (US$ Million), 2023–2031
7. Bioprocessing Market Analysis – by Product
7.1 Overview
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
7.2.2.1 Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – By Instruments
7.2.2.1.1 Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – By Bioreactors
7.2.2.1.2 Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – By Chromatography Systems
7.3 Consumables and Accessories
7.3.1 Overview
7.3.2 Consumables and Accessories: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
7.3.2.1 Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – By Consumables and Accessories
8. Bioprocessing Market Analysis – by Scale Of Operation
8.1 Overview
8.2 Commercial Operations
8.2.1 Overview
8.2.2 Commercial Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
8.3.1 Overview
8.3.2 Clinical Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9. Bioprocessing Market Analysis – by Process
9.1 Overview
9.2 Downstream Bioprocess
9.2.1 Overview
9.2.2 Downstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
9.3.1 Overview
9.3.2 Upstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10. Bioprocessing Market Analysis – by Application
10.1 Overview
10.2 Monoclonal Antibodies
10.2.1 Overview
10.2.2 Monoclonal Antibodies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
10.3.1 Overview
10.3.2 Vaccines: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
10.4.1 Overview
10.4.2 Recombinant Protein: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Cell and Gene Therapy
10.5.1 Overview
10.5.2 Cell and Gene Therapy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11. Bioprocessing Market Analysis – by End User
11.1 Overview
11.2 Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Biopharmaceutical Companies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
11.3.1 Overview
11.3.2 Contract Manufacturing Organization: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12. Bioprocessing Market – Geographical Analysis
12.1 North America: Bioprocessing Market
12.1.1 Overview
12.1.2 North America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.2.1 North America: Bioprocessing Market – Revenue and Forecast Analysis – by Product
12.1.2.1.1 North America: Bioprocessing Market – Revenue and Forecast Analysis – by Instruments
12.1.2.1.1.1 North America: Bioprocessing Market – Revenue and Forecast Analysis – by Bioreactors
12.1.2.1.1.2 North America: Bioprocessing Market – Revenue and Forecast Analysis – by Chromatography Systems
12.1.2.1.2 North America: Bioprocessing Market – Revenue and Forecast Analysis – by Consumables And Accessories
12.1.2.2 North America: Bioprocessing Market – Revenue and Forecast Analysis – by Scale Of Operation
12.1.2.3 North America: Bioprocessing Market – Revenue and Forecast Analysis – by Process
12.1.2.4 North America: Bioprocessing Market – Revenue and Forecast Analysis – by Application
12.1.2.5 North America: Bioprocessing Market – Revenue and Forecast Analysis – by End User
12.1.3 North America: Bioprocessing Market – Revenue and Forecast Analysis – by Country
12.1.3.1 United States: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.3.1.1 Overview
12.1.3.2 United States: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.3.2.1 United States: Bioprocessing Market Breakdown, by Product
12.1.3.2.1.1 United States: Bioprocessing Market Breakdown, by Instruments
12.1.3.2.1.1.1 United States: Bioprocessing Market Breakdown, by Bioreactors
12.1.3.2.1.1.2 United States: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.3.2.1.2 United States: Bioprocessing Market Breakdown, by Consumables And Accessories
12.1.3.2.2 United States: Bioprocessing Market Breakdown, by Scale Of Operation
12.1.3.2.3 United States: Bioprocessing Market Breakdown, by Process
12.1.3.2.4 United States: Bioprocessing Market Breakdown, by Application
12.1.3.2.5 United States: Bioprocessing Market Breakdown, by End User
12.1.3.3 Canada: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.3.3.1 Overview
12.1.3.4 Canada: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.3.4.1 Canada: Bioprocessing Market Breakdown, by Product
12.1.3.4.1.1 Canada: Bioprocessing Market Breakdown, by Instruments
12.1.3.4.1.1.1 Canada: Bioprocessing Market Breakdown, by Bioreactors
12.1.3.4.1.1.2 Canada: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.3.4.1.2 Canada: Bioprocessing Market Breakdown, by Consumables and Accessories
12.1.3.4.2 Canada: Bioprocessing Market Breakdown, by Scale of Operation
12.1.3.4.3 Canada: Bioprocessing Market Breakdown, by Process
12.1.3.4.4 Canada: Bioprocessing Market Breakdown, by Application
12.1.3.4.5 Canada: Bioprocessing Market Breakdown, by End User
12.1.3.5 Mexico: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.3.5.1 Overview
12.1.3.6 Mexico: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.1.3.6.1 Mexico: Bioprocessing Market Breakdown, by Product
12.1.3.6.1.1 Mexico: Bioprocessing Market Breakdown, by Instruments
12.1.3.6.1.1.1 Mexico: Bioprocessing Market Breakdown, by Bioreactors
12.1.3.6.1.1.2 Mexico: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.3.6.1.2 Mexico: Bioprocessing Market Breakdown, by Consumables And Accessories
12.1.3.6.2 Mexico: Bioprocessing Market Breakdown, by Scale Of Operation
12.1.3.6.3 Mexico: Bioprocessing Market Breakdown, by Process
12.1.3.6.4 Mexico: Bioprocessing Market Breakdown, by Application
12.1.3.6.5 Mexico: Bioprocessing Market Breakdown, by End User
12.2 Europe: Bioprocessing Market
12.2.1 Overview
12.2.2 Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.2.2.1 Europe: Bioprocessing Market – Revenue and Forecast Analysis – by Product
12.2.2.1.1 Europe: Bioprocessing Market – Revenue and Forecast Analysis – by Instruments
12.2.2.1.1.1 Europe: Bioprocessing Market – Revenue and Forecast Analysis – by Bioreactors
12.2.2.1.1.2 Europe: Bioprocessing Market – Revenue and Forecast Analysis – by Chromatography Systems
12.2.2.1.2 Europe: Bioprocessing Market – Revenue and Forecast Analysis – by Consumables And Accessories
12.2.2.2 Europe: Bioprocessing Market – Revenue and Forecast Analysis – by Scale Of Operation
12.2.2.3 Europe: Bioprocessing Market – Revenue and Forecast Analysis – by Process
12.2.2.4 Europe: Bioprocessing Market – Revenue and Forecast Analysis – by Application
12.2.2.5 Europe: Bioprocessing Market – Revenue and Forecast Analysis – by End User
12.2.3 Europe: Bioprocessing Market – Revenue and Forecast Analysis – by Country
12.2.3.1 Germany: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.2.3.1.1 Overview
12.2.3.2 Germany: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.2.3.2.1 Germany: Bioprocessing Market Breakdown, by Product
12.2.3.2.1.1 Germany: Bioprocessing Market Breakdown, by Instruments
12.2.3.2.1.1.1 Germany: Bioprocessing Market Breakdown, by Bioreactors
12.2.3.2.1.1.2 Germany: Bioprocessing Market Breakdown, by Chromatography Systems
12.2.3.2.1.2 Germany: Bioprocessing Market Breakdown, by Consumables And Accessories
12.2.3.2.2 Germany: Bioprocessing Market Breakdown, by Scale Of Operation
12.2.3.2.3 Germany: Bioprocessing Market Breakdown, by Process
12.2.3.2.4 Germany: Bioprocessing Market Breakdown, by Application
12.2.3.2.5 Germany: Bioprocessing Market Breakdown, by End User
12.2.3.3 United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.2.3.3.1 Overview
12.2.3.4 United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.2.3.4.1 United Kingdom: Bioprocessing Market Breakdown, by Product
12.2.3.4.1.1 United Kingdom: Bioprocessing Market Breakdown, by Instruments
12.2.3.4.1.1.1 United Kingdom: Bioprocessing Market Breakdown, by Bioreactors
12.2.3.4.1.1.2 United Kingdom: Bioprocessing Market Breakdown, by Chromatography Systems
12.2.3.4.1.2 United Kingdom: Bioprocessing Market Breakdown, by Consumables And Accessories
12.2.3.4.2 United Kingdom: Bioprocessing Market Breakdown, by Scale Of Operation
12.2.3.4.3 United Kingdom: Bioprocessing Market Breakdown, by Process
12.2.3.4.4 United Kingdom: Bioprocessing Market Breakdown, by Application
12.2.3.4.5 United Kingdom: Bioprocessing Market Breakdown, by End User
12.2.3.5 France: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.2.3.5.1 Overview
12.2.3.6 France: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.2.3.6.1 France: Bioprocessing Market Breakdown, by Product
12.2.3.6.1.1 France: Bioprocessing Market Breakdown, by Instruments
12.2.3.6.1.1.1 France: Bioprocessing Market Breakdown, by Bioreactors
12.2.3.6.1.1.2 France: Bioprocessing Market Breakdown, by Chromatography Systems
12.2.3.6.1.2 France: Bioprocessing Market Breakdown, by Consumables And Accessories
12.2.3.6.2 France: Bioprocessing Market Breakdown, by Scale Of Operation
12.2.3.6.3 France: Bioprocessing Market Breakdown, by Process
12.2.3.6.4 France: Bioprocessing Market Breakdown, by Application
12.2.3.6.5 France: Bioprocessing Market Breakdown, by End User
12.2.3.7 Italy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.2.3.7.1 Overview
12.2.3.8 Italy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.2.3.8.1 Italy: Bioprocessing Market Breakdown, by Product
12.2.3.8.1.1 Italy: Bioprocessing Market Breakdown, by Instruments
12.2.3.8.1.1.1 Italy: Bioprocessing Market Breakdown, by Bioreactors
12.2.3.8.2 Italy: Bioprocessing Market Breakdown, by Chromatography Systems
12.2.3.8.2.1 Italy: Bioprocessing Market Breakdown, by Consumables And Accessories
12.2.3.8.3 Italy: Bioprocessing Market Breakdown, by Scale Of Operation
12.2.3.8.4 Italy: Bioprocessing Market Breakdown, by Process
12.2.3.8.5 Italy: Bioprocessing Market Breakdown, by Application
12.2.3.8.6 Italy: Bioprocessing Market Breakdown, by End User
12.2.3.9 Spain: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.2.3.9.1 Overview
12.2.3.10 Spain: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.2.3.10.1 Spain: Bioprocessing Market Breakdown, by Product
12.2.3.10.1.1 Spain: Bioprocessing Market Breakdown, by Instruments
12.2.3.10.1.1.1 Spain: Bioprocessing Market Breakdown, by Bioreactors
12.2.3.10.1.1.2 Spain: Bioprocessing Market Breakdown, by Chromatography Systems
12.2.3.10.1.2 Spain: Bioprocessing Market Breakdown, by Consumables and Accessories
12.2.3.10.2 Spain: Bioprocessing Market Breakdown, by Scale Of Operation
12.2.3.10.3 Spain: Bioprocessing Market Breakdown, by Process
12.2.3.10.4 Spain: Bioprocessing Market Breakdown, by Application
12.2.3.10.5 Spain: Bioprocessing Market Breakdown, by End User
12.2.3.11 Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.2.3.11.1 Overview
12.2.3.12 Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.2.3.12.1 Rest of Europe: Bioprocessing Market Breakdown, by Product
12.2.3.12.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Instruments
12.2.3.12.1.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Bioreactors
12.2.3.12.1.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Chromatography Systems
12.2.3.12.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Consumables and Accessories
12.2.3.12.2 Rest of Europe: Bioprocessing Market Breakdown, by Scale Of Operation
12.2.3.12.3 Rest of Europe: Bioprocessing Market Breakdown, by Process
12.2.3.12.4 Rest of Europe: Bioprocessing Market Breakdown, by Application
12.2.3.12.5 Rest of Europe: Bioprocessing Market Breakdown, by End User
12.3 Asia Pacific: Bioprocessing Market
12.3.1 Overview
12.3.2 Asia Pacific: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.3.2.1 Asia Pacific: Bioprocessing Market – Revenue and Forecast Analysis – by Product
12.3.2.1.1 Asia Pacific: Bioprocessing Market – Revenue and Forecast Analysis – by Instruments
12.3.2.1.1.1 Asia Pacific: Bioprocessing Market – Revenue and Forecast Analysis – by Bioreactors
12.3.2.1.1.2 Asia Pacific: Bioprocessing Market – Revenue and Forecast Analysis – by Chromatography Systems
12.3.2.1.2 Asia Pacific: Bioprocessing Market – Revenue and Forecast Analysis – by Consumables and Accessories
12.3.2.2 Asia Pacific: Bioprocessing Market – Revenue and Forecast Analysis – by Scale of Operation
12.3.2.3 Asia Pacific: Bioprocessing Market – Revenue and Forecast Analysis – by Process
12.3.2.4 Asia Pacific: Bioprocessing Market – Revenue and Forecast Analysis – by Application
12.3.2.5 Asia Pacific: Bioprocessing Market – Revenue and Forecast Analysis – by End User
12.3.3 Asia Pacific: Bioprocessing Market – Revenue and Forecast Analysis – by Country
12.3.3.1 China: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.3.3.1.1 Overview
12.3.3.2 China: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.3.3.2.1 China: Bioprocessing Market Breakdown, by Product
12.3.3.2.1.1 China: Bioprocessing Market Breakdown, by Instruments
12.3.3.2.1.1.1 China: Bioprocessing Market Breakdown, by Bioreactors
12.3.3.2.1.1.2 China: Bioprocessing Market Breakdown, by Chromatography Systems
12.3.3.2.2 China: Bioprocessing Market Breakdown, by Consumables And Accessories
12.3.3.2.3 China: Bioprocessing Market Breakdown, by Scale Of Operation
12.3.3.2.4 China: Bioprocessing Market Breakdown, by Process
12.3.3.2.5 China: Bioprocessing Market Breakdown, by Application
12.3.3.2.6 China: Bioprocessing Market Breakdown, by End User
12.3.3.3 India: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.3.3.3.1 Overview
12.3.3.4 India: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.3.3.4.1 India: Bioprocessing Market Breakdown, by Product
12.3.3.4.1.1 India: Bioprocessing Market Breakdown, by Instruments
12.3.3.4.1.1.1 India: Bioprocessing Market Breakdown, by Bioreactors
12.3.3.4.1.1.2 India: Bioprocessing Market Breakdown, by Chromatography Systems
12.3.3.4.1.2 India: Bioprocessing Market Breakdown, by Consumables And Accessories
12.3.3.4.2 India: Bioprocessing Market Breakdown, by Scale Of Operation
12.3.3.4.3 India: Bioprocessing Market Breakdown, by Process
12.3.3.4.4 India: Bioprocessing Market Breakdown, by Application
12.3.3.4.5 India: Bioprocessing Market Breakdown, by End User
12.3.3.5 Japan: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.3.3.5.1 Overview
12.3.3.6 Japan: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.3.3.6.1 Japan: Bioprocessing Market Breakdown, by Product
12.3.3.6.1.1 Japan: Bioprocessing Market Breakdown, by Instruments
12.3.3.6.1.1.1 Japan: Bioprocessing Market Breakdown, by Bioreactors
12.3.3.6.1.1.2 Japan: Bioprocessing Market Breakdown, by Chromatography Systems
12.3.3.6.1.2 Japan: Bioprocessing Market Breakdown, by Consumables and Accessories
12.3.3.6.2 Japan: Bioprocessing Market Breakdown, by Scale Of Operation
12.3.3.6.3 Japan: Bioprocessing Market Breakdown, by Process
12.3.3.6.4 Japan: Bioprocessing Market Breakdown, by Application
12.3.3.6.5 Japan: Bioprocessing Market Breakdown, by End User
12.3.3.7 South Korea: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.3.3.7.1 Overview
12.3.3.8 South Korea: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.3.3.8.1 South Korea: Bioprocessing Market Breakdown, by Product
12.3.3.8.1.1 South Korea: Bioprocessing Market Breakdown, by Instruments
12.3.3.8.1.1.1 South Korea: Bioprocessing Market Breakdown, by Bioreactors
12.3.3.8.1.1.2 South Korea: Bioprocessing Market Breakdown, by Chromatography Systems
12.3.3.8.1.2 South Korea: Bioprocessing Market Breakdown, by Consumables And Accessories
12.3.3.8.2 South Korea: Bioprocessing Market Breakdown, by Scale Of Operation
12.3.3.8.3 South Korea: Bioprocessing Market Breakdown, by Process
12.3.3.8.4 South Korea: Bioprocessing Market Breakdown, by Application
12.3.3.8.5 South Korea: Bioprocessing Market Breakdown, by End User
12.3.3.9 Australia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.3.3.9.1 Overview
12.3.3.10 Australia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.3.3.10.1 Australia: Bioprocessing Market Breakdown, by Product
12.3.3.10.1.1 Australia: Bioprocessing Market Breakdown, by Instruments
12.3.3.10.1.1.1 Australia: Bioprocessing Market Breakdown, by Bioreactors
12.3.3.10.1.1.2 Australia: Bioprocessing Market Breakdown, by Chromatography Systems
12.3.3.10.1.2 Australia: Bioprocessing Market Breakdown, by Consumables and Accessories
12.3.3.10.2 Australia: Bioprocessing Market Breakdown, by Scale Of Operation
12.3.3.10.3 Australia: Bioprocessing Market Breakdown, by Process
12.3.3.10.4 Australia: Bioprocessing Market Breakdown, by Application
12.3.3.10.5 Australia: Bioprocessing Market Breakdown, by End User
12.3.3.11 Rest of APAC: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.3.3.11.1 Overview
12.3.3.12 Rest of APAC: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.3.3.12.1 Rest of APAC: Bioprocessing Market Breakdown, by Product
12.3.3.12.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Instruments
12.3.3.12.1.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Bioreactors
12.3.3.12.1.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Chromatography Systems
12.3.3.12.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Consumables And Accessories
12.3.3.12.2 Rest of APAC: Bioprocessing Market Breakdown, by Scale Of Operation
12.3.3.12.3 Rest of APAC: Bioprocessing Market Breakdown, by Process
12.3.3.12.4 Rest of APAC: Bioprocessing Market Breakdown, by Application
12.3.3.12.5 Rest of APAC: Bioprocessing Market Breakdown, by End User
12.4 Middle East & Africa: Bioprocessing Market
12.4.1 Overview
12.4.2 Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.4.2.1 Middle East & Africa: Bioprocessing Market – Revenue and Forecast Analysis – by Product
12.4.2.1.1 Middle East & Africa: Bioprocessing Market – Revenue and Forecast Analysis – by Instruments
12.4.2.1.1.1 Middle East & Africa: Bioprocessing Market – Revenue and Forecast Analysis – by Bioreactors
12.4.2.1.1.2 Middle East & Africa: Bioprocessing Market – Revenue and Forecast Analysis – by Chromatography Systems
12.4.2.1.2 Middle East & Africa: Bioprocessing Market – Revenue and Forecast Analysis – by Consumables And Accessories
12.4.2.2 Middle East & Africa: Bioprocessing Market – Revenue and Forecast Analysis – by Scale Of Operation
12.4.2.3 Middle East & Africa: Bioprocessing Market – Revenue and Forecast Analysis – by Process
12.4.2.4 Middle East & Africa: Bioprocessing Market – Revenue and Forecast Analysis – by Application
12.4.2.5 Middle East & Africa: Bioprocessing Market – Revenue and Forecast Analysis – by End User
12.4.3 Middle East & Africa: Bioprocessing Market – Revenue and Forecast Analysis – by Country
12.4.3.1 Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.4.3.1.1 Overview
12.4.3.2 Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.4.3.2.1 Saudi Arabia: Bioprocessing Market Breakdown, by Product
12.4.3.2.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Instruments
12.4.3.2.1.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Bioreactors
12.4.3.2.1.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Chromatography Systems
12.4.3.2.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Consumables And Accessories
12.4.3.2.2 Saudi Arabia: Bioprocessing Market Breakdown, by Scale Of Operation
12.4.3.2.3 Saudi Arabia: Bioprocessing Market Breakdown, by Process
12.4.3.2.4 Saudi Arabia: Bioprocessing Market Breakdown, by Application
12.4.3.2.5 Saudi Arabia: Bioprocessing Market Breakdown, by End User
12.4.3.3 South Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.4.3.3.1 Overview
12.4.3.4 South Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.4.3.4.1 South Africa: Bioprocessing Market Breakdown, by Product
12.4.3.4.1.1 South Africa: Bioprocessing Market Breakdown, by Instruments
12.4.3.4.1.1.1 South Africa: Bioprocessing Market Breakdown, by Bioreactors
12.4.3.4.1.1.2 South Africa: Bioprocessing Market Breakdown, by Chromatography Systems
12.4.3.4.1.2 South Africa: Bioprocessing Market Breakdown, by Consumables And Accessories
12.4.3.4.2 South Africa: Bioprocessing Market Breakdown, by Scale Of Operation
12.4.3.4.3 South Africa: Bioprocessing Market Breakdown, by Process
12.4.3.4.4 South Africa: Bioprocessing Market Breakdown, by Application
12.4.3.4.5 South Africa: Bioprocessing Market Breakdown, by End User
12.4.3.5 United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.4.3.5.1 Overview
12.4.3.6 United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.4.3.6.1 United Arab Emirates: Bioprocessing Market Breakdown, by Product
12.4.3.6.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Instruments
12.4.3.6.1.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Bioreactors
12.4.3.6.1.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Chromatography Systems
12.4.3.6.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Consumables And Accessories
12.4.3.6.2 United Arab Emirates: Bioprocessing Market Breakdown, by Scale Of Operation
12.4.3.6.3 United Arab Emirates: Bioprocessing Market Breakdown, by Process
12.4.3.6.4 United Arab Emirates: Bioprocessing Market Breakdown, by Application
12.4.3.6.5 United Arab Emirates: Bioprocessing Market Breakdown, by End User
12.4.3.7 Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.4.3.7.1 Overview
12.4.3.8 Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.4.3.8.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Product
12.4.3.8.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Instruments
12.4.3.8.1.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Bioreactors
12.4.3.8.1.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Chromatography Systems
12.4.3.8.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Consumables And Accessories
12.4.3.8.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Scale Of Operation
12.4.3.8.3 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Process
12.4.3.8.4 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Application
12.4.3.8.5 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by End User
12.5 South & Central America: Bioprocessing Market
12.5.1 Overview
12.5.2 South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.5.2.1 South & Central America: Bioprocessing Market – Revenue and Forecast Analysis – by Product
12.5.2.1.1 South & Central America: Bioprocessing Market – Revenue and Forecast Analysis – by Instruments
12.5.2.1.1.1 South & Central America: Bioprocessing Market – Revenue and Forecast Analysis – by Bioreactors
12.5.2.1.1.2 South & Central America: Bioprocessing Market – Revenue and Forecast Analysis – by Chromatography Systems
12.5.2.1.2 South & Central America: Bioprocessing Market – Revenue and Forecast Analysis – by Consumables And Accessories
12.5.2.2 South & Central America: Bioprocessing Market – Revenue and Forecast Analysis – by Scale Of Operation
12.5.2.3 South & Central America: Bioprocessing Market – Revenue and Forecast Analysis – by Process
12.5.2.4 South & Central America: Bioprocessing Market – Revenue and Forecast Analysis – by Application
12.5.2.5 South & Central America: Bioprocessing Market – Revenue and Forecast Analysis – by End User
12.5.3 South & Central America: Bioprocessing Market – Revenue and Forecast Analysis – by Country
12.5.3.1 Brazil: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.5.3.1.1 Overview
12.5.3.2 Brazil: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.5.3.2.1 Brazil: Bioprocessing Market Breakdown, by Product
12.5.3.2.1.1 Brazil: Bioprocessing Market Breakdown, by Instruments
12.5.3.2.1.1.1 Brazil: Bioprocessing Market Breakdown, by Bioreactors
12.5.3.2.1.1.2 Brazil: Bioprocessing Market Breakdown, by Chromatography Systems
12.5.3.2.1.2 Brazil: Bioprocessing Market Breakdown, by Consumables And Accessories
12.5.3.2.2 Brazil: Bioprocessing Market Breakdown, by Scale Of Operation
12.5.3.2.3 Brazil: Bioprocessing Market Breakdown, by Process
12.5.3.2.4 Brazil: Bioprocessing Market Breakdown, by Application
12.5.3.2.5 Brazil: Bioprocessing Market Breakdown, by End User
12.5.3.3 Argentina: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.5.3.3.1 Overview
12.5.3.4 Argentina: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.5.3.4.1 Argentina: Bioprocessing Market Breakdown, by Product
12.5.3.4.1.1 Argentina: Bioprocessing Market Breakdown, by Instruments
12.5.3.4.1.1.1 Argentina: Bioprocessing Market Breakdown, by Bioreactors
12.5.3.4.1.1.2 Argentina: Bioprocessing Market Breakdown, by Chromatography Systems
12.5.3.4.1.2 Argentina: Bioprocessing Market Breakdown, by Consumables And Accessories
12.5.3.4.2 Argentina: Bioprocessing Market Breakdown, by Scale Of Operation
12.5.3.4.3 Argentina: Bioprocessing Market Breakdown, by Process
12.5.3.4.4 Argentina: Bioprocessing Market Breakdown, by Application
12.5.3.4.5 Argentina: Bioprocessing Market Breakdown, by End User
12.5.3.5 Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.5.3.5.1 Overview
12.5.3.6 Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
12.5.3.6.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Product
12.5.3.6.1.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Instruments
12.5.3.6.1.1.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Bioreactors
12.5.3.6.1.1.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Chromatography Systems
12.5.3.6.1.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Consumables And Accessories
12.5.3.6.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Scale Of Operation
12.5.3.6.3 Rest of South & Central America: Bioprocessing Market Breakdown, by Process
12.5.3.6.4 Rest of South & Central America: Bioprocessing Market Breakdown, by Application
12.5.3.6.5 Rest of South & Central America: Bioprocessing Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Getinge AB
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sartorius AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Corning Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 3M Co
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Eppendorf SE
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Repligen Corp
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Entegris Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Agilent Technologies Inc
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Cytiva US LLC
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
15. Appendix
15.1 About the Research Team
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Bioprocessing Market Segmentation
Table 2. List of Vendors
Table 3. Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – By Instruments
Table 4. Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – By Bioreactors
Table 5. Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – By Chromatography Systems
Table 6. Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – By Consumables and Accessories
Table 7. North America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 8. North America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 9. North America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 10. North America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 11. North America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 12. North America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 13. North America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 14. North America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 15. North America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 16. United States: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 17. United States: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 18. United States: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 19. United States: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 20. United States: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 21. United States: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 22. United States: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 23. United States: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 24. United States: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 25. Canada: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 26. Canada: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 27. Canada: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 28. Canada: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 29. Canada: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 30. Canada: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale of Operation
Table 31. Canada: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 32. Canada: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 33. Canada: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 34. Mexico: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 35. Mexico: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 36. Mexico: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 37. Mexico: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 38. Mexico: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 39. Mexico: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 40. Mexico: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 41. Mexico: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 42. Mexico: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 43. Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 44. Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 45. Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 46. Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 47. Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 48. Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 49. Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 50. Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 51. Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 52. Germany: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 53. Germany: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 54. Germany: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 55. Germany: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 56. Germany: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 57. Germany: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 58. Germany: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 59. Germany: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 60. Germany: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 61. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 62. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 63. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 64. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 65. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 66. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 67. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 68. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 69. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 70. France: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 71. France: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 72. France: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 73. France: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 74. France: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 75. France: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 76. France: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 77. France: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 78. France: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 79. Italy: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 80. Italy: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 81. Italy: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 82. Italy: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 83. Italy: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 84. Italy: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 85. Italy: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 86. Italy: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 87. Italy: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 88. Spain: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 89. Spain: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 90. Spain: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 91. Spain: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 92. Spain: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 93. Spain: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 94. Spain: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 95. Spain: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 96. Spain: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 97. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 98. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 99. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 100. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 101. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 102. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 103. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 104. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 105. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 106. Asia Pacific: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 107. Asia Pacific: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 108. Asia Pacific: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 109. Asia Pacific: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 110. Asia Pacific: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables and Accessories
Table 111. Asia Pacific: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 112. Asia Pacific: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 113. Asia Pacific: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 114. Asia Pacific: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 115. China: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 116. China: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 117. China: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 118. China: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 119. China: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 120. China: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 121. China: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 122. China: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 123. China: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 124. India: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 125. India: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 126. India: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 127. India: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 128. India: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 129. India: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 130. India: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 131. India: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 132. India: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 133. Japan: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 134. Japan: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 135. Japan: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 136. Japan: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 137. Japan: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 138. Japan: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 139. Japan: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 140. Japan: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 141. Japan: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 142. South Korea: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 143. South Korea: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 144. South Korea: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 145. South Korea: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 146. South Korea: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 147. South Korea: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 148. South Korea: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 149. South Korea: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 150. South Korea: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 151. Australia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 152. Australia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 153. Australia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 154. Australia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 155. Australia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 156. Australia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 157. Australia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 158. Australia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 159. Australia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 160. Rest of APAC: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 161. Rest of APAC: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 162. Rest of APAC: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 163. Rest of APAC: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 164. Rest of APAC: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables and Accessories
Table 165. Rest of APAC: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 166. Rest of APAC: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 167. Rest of APAC: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 168. Rest of APAC: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 169. Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 170. Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 171. Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 172. Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 173. Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 174. Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 175. Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 176. Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 177. Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 178. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 179. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 180. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 181. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 182. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 183. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 184. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 185. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 186. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 187. South Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 188. South Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 189. South Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 190. South Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 191. South Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 192. South Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 193. South Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 194. South Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 195. South Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 196. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 197. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 198. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 199. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 200. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 201. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 202. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 203. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 204. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 205. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 206. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 207. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 208. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 209. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 210. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 211. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 212. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 213. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 214. South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 215. South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 216. South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 217. South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 218. South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 219. South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 220. South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 221. South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 222. South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 223. Brazil: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 224. Brazil: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 225. Brazil: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 226. Brazil: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 227. Brazil: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 228. Brazil: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 229. Brazil: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 230. Brazil: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 231. Brazil: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 232. Argentina: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 233. Argentina: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 234. Argentina: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 235. Argentina: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 236. Argentina: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 237. Argentina: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale Of Operation
Table 238. Argentina: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 239. Argentina: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 240. Argentina: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 241. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Product
Table 242. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Instruments
Table 243. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Bioreactors
Table 244. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Chromatography Systems
Table 245. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Consumables And Accessories
Table 246. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Scale of Operation
Table 247. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Process
Table 248. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 249. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 250. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 251. Recent Organic Growth Strategies in the Bioprocessing Market
Table 252. Glossary of Terms, Bioprocessing Market
LIST OF FIGURES
Figure 1. Bioprocessing Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2023–2031
Figure 5. Bioprocessing Market Breakdown by Geography, 2023 and 2031 (%)
Figure 6. Bioprocessing Market Share (%) – by Product (2023 and 2031)
Figure 7. Instruments: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Consumables and Accessories: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Bioprocessing Market Share (%) – by Scale Of Operation (2023 and 2031)
Figure 10. Commercial Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Clinical Operations: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Bioprocessing Market Share (%) – by Process (2023 and 2031)
Figure 13. Downstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Upstream Bioprocess: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Bioprocessing Market Share (%) – by Application (2023 and 2031)
Figure 16. Monoclonal Antibodies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Vaccines: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Recombinant Protein: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Cell and Gene Therapy: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Bioprocessing Market Share (%) – by End User (2023 and 2031)
Figure 22. Biopharmaceutical Companies: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Contract Manufacturing Organization: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Others: Bioprocessing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 25. North America: Bioprocessing Market, by Key Country – Revenue (2023) (US$ Million)
Figure 26. North America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 27. North America: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 28. United States: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 29. Canada: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 30. Mexico: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 31. Europe: Bioprocessing Market, by Key Country – Revenue (2023) (US$ Million)
Figure 32. Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 34. Germany: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. United Kingdom: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. France: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. Italy: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. Spain: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 39. Rest of Europe: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. Asia Pacific: Bioprocessing Market, by Key Country – Revenue (2023) (US$ Million)
Figure 41. Asia Pacific: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 43. China: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. India: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Japan: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. South Korea: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. Australia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 48. Rest of APAC: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 49. Middle East & Africa: Bioprocessing Market, by Key Country – Revenue (2023) (US$ Million)
Figure 50. Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 51. Middle East & Africa: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 52. Saudi Arabia: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. South Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. United Arab Emirates: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. Rest of Middle East & Africa: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. South & Central America: Bioprocessing Market, by Key Country – Revenue (2023) (US$ Million)
Figure 57. South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 58. South & Central America: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 59. Brazil: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 60. Argentina: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 61. Rest of South & Central America: Bioprocessing Market – Revenue and Forecast to 2031(US$ Million)
Figure 62. Growth Strategies in the Bioprocessing Market
The List of Companies – Bioprocessing Market
o Cytiva (Danaher Corporation)
o Sartorius AG
o Thermo Fisher Scientific Inc.
o Repligen Corporation
o Merck KgaA
o 3M Company
o Getinge AB
o Eppendorf SE
o Corning Incorporated
o Entegris
o Agilent Technologies
o Bio-Rad Laboratories
You must be logged in to post a review.
Reviews
There are no reviews yet.